Andrew Talal can speak to media about advances in diagnosing and treating liver disease, including hepatitis C virus, especially in hard-to-treat populations. He is principal investigator on a $7 million Patient-Centered Outcomes Research Institute (PCORI) award to study innovations he has helped...
Andrew Talal can speak to media about advances in diagnosing and treating liver disease, including hepatitis C virus, especially in hard-to-treat populations. He is principal investigator on a $7 million Patient-Centered Outcomes Research Institute (PCORI) award to study innovations he has helped develop to treat liver disease, especially HCV, in people with substance use disorders.These innovations include telehealth approaches and the use of methadone treatment clinics in effectively diagnosing and treating liver disease in patients of these clinics.Talal and his colleagues work with patients at the liver clinics at Erie County Medical Center and at Buffalo General Medical Center.